The risk or severity of adverse effects can be increased when benzocaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when ESMOLOL is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when benzocaine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when promazine is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when metoprolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when methoxamine is combined with phenmetrazine.


The risk or severity of adverse effects can be increased when ketamine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Levetiracetam is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when MEPHENTERMINE is combined with PROCATEROL.


The risk or severity of adverse effects can be increased when trandolapril is combined with metolazone.


The risk or severity of adverse effects can be increased when trandolapril is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with carisoprodol.


The risk or severity of adverse effects can be increased when codeine is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with oxycodone.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when gabapentin is combined with oxprenolol.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Atracurium besylate is combined with methscopolamine.


The risk or severity of adverse effects can be increased when Halazepam is combined with clemastine.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with fludrocortisone.


The risk or severity of adverse effects can be increased when Halazepam is combined with venlafaxine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with MELPERONE.


The risk or severity of adverse effects can be increased when morniflumate is combined with salicylamide.


The risk or severity of adverse effects can be increased when halothane is combined with Propoxycaine.


The risk or severity of adverse effects can be increased when selegiline is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when carisoprodol is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when Sodium oxybate is combined with Escitalopram.


The risk or severity of adverse effects can be increased when fenoldopam is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when BENZYDAMINE is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when rizatriptan is combined with prochlorperazine.


The risk or severity of adverse effects can be increased when Zuclopenthixol is combined with zonisamide.


The risk or severity of adverse effects can be increased when Bortezomib is combined with Phenelzine.


The risk or severity of adverse effects can be increased when Cilastatin is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when pergolide is combined with rapamycin.


The risk or severity of adverse effects can be increased when butabarbital is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when tretinoin is combined with carvedilol.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with dantrolene.


The risk or severity of adverse effects can be increased when Torasemide is combined with ouabain.


The risk or severity of adverse effects can be increased when fexofenadine is combined with citalopram.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with minoxidil.


The risk or severity of adverse effects can be increased when butabarbital is combined with amitriptyline.


The risk or severity of adverse effects can be increased when butabarbital is combined with hydromorphone.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when Pipamperone is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Perospirone is combined with zonisamide.


The risk or severity of adverse effects can be increased when celecoxib is combined with suprofen.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Difenoxin.


The risk or severity of adverse effects can be increased when Perospirone is combined with tiagabine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Perospirone.


The risk or severity of adverse effects can be increased when salicylic acid is combined with ketoprofen.


The risk or severity of adverse effects can be increased when TRICHLOROETHYLENE is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when clozapine is combined with Etomidate.


The risk or severity of adverse effects can be increased when oxazepam is combined with tizanidine.


The risk or severity of adverse effects can be increased when sumatriptan is combined with Almotriptan.


The risk or severity of adverse effects can be increased when clozapine is combined with morphine.


The risk or severity of adverse effects can be increased when maprotiline is combined with ACETOPHENAZINE.


The risk or severity of adverse effects can be increased when Rufinamide is combined with trifluoperazine.


The risk or severity of adverse effects can be increased when celecoxib is combined with sulindac.


The risk or severity of adverse effects can be increased when Agomelatine is combined with clonidine.


The risk or severity of adverse effects can be increased when nicergoline is combined with Posaconazole.


The risk or severity of adverse effects can be increased when Halazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when mesalamine is combined with equilin.


The risk or severity of adverse effects can be increased when Halazepam is combined with methocarbamol.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when codeine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Escitalopram.


The risk or severity of adverse effects can be increased when loteprednol is combined with NEOSTIGMINE.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Methylscopolamine bromide is combined with oxycodone.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with Perospirone.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Nepafenac is combined with DESONIDE.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with methazolamide.


The risk or severity of adverse effects can be increased when Enalaprilat is combined with ropinirole.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with tizanidine.


The risk or severity of adverse effects can be increased when clozapine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when cocaine is combined with Fospropofol.


The risk or severity of adverse effects can be increased when triflupromazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when isradipine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when clozapine is combined with scopolamine.


The risk or severity of adverse effects can be increased when mecamylamine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when Eszopiclone is combined with maprotiline.


The risk or severity of adverse effects can be increased when AMPHETAMINE is combined with terbutaline.


The risk or severity of adverse effects can be increased when pergolide is combined with diethylstilbestrol.


The risk or severity of adverse effects can be increased when aspirin is combined with epirizole.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with fexofenadine.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when tolfenamic acid is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Salsalate.


The risk or severity of adverse effects can be increased when Nepafenac is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when Vecuronium is combined with nalbuphine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with salicylamide.


The risk or severity of adverse effects can be increased when butabarbital is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with dibucaine.


The risk or severity of adverse effects can be increased when trandolapril is combined with cilazapril.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with glutethimide.


The risk or severity of adverse effects can be increased when procaine is combined with Mephobarbital.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with rasagiline.


The risk or severity of adverse effects can be increased when venlafaxine is combined with maprotiline.


The risk or severity of adverse effects can be increased when methadone is combined with Paliperidone.


The risk or severity of adverse effects can be increased when Glycopyrronium is combined with pentazocine.


The risk or severity of adverse effects can be increased when etodolac is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when ethotoin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when cerulenin is combined with manidipine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with CLONIXIN.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with gabapentin.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Droxicam.


The risk or severity of adverse effects can be increased when PIRFENIDONE is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with Etomidate.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with sulpiride.


The risk or severity of adverse effects can be increased when isoflurane is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when enflurane is combined with Agomelatine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Ramelteon.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with tetracaine.


The risk or severity of adverse effects can be increased when eperisone is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when reserpine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when gabapentin is combined with Ramelteon.


The risk or severity of adverse effects can be increased when fluocinonide is combined with donepezil.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when gabapentin is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ropinirole.


The risk or severity of adverse effects can be increased when Magnesium salicylate is combined with alclofenac.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with dexamethasone.


The risk or severity of adverse effects can be increased when Olopatadine is combined with levodopa.


The risk or severity of adverse effects can be increased when Carbetocin is combined with metoprolol.


The risk or severity of adverse effects can be increased when ramipril is combined with Pimecrolimus.


The risk or severity of adverse effects can be increased when penbutolol is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Fluticasone furoate.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with formestane.


The risk or severity of adverse effects can be increased when buspirone is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when salicylic acid is combined with nitrendipine.


The risk or severity of adverse effects can be increased when isocarboxazid is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with oxprenolol.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with glutethimide.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Dimethyl fumarate.


The risk or severity of adverse effects can be increased when VORTIOXETINE is combined with Flibanserin.


The risk or severity of adverse effects can be increased when nicergoline is combined with cisapride.


The risk or severity of adverse effects can be increased when MOLINDONE is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with MAGNESIUM SULFATE.


The risk or severity of adverse effects can be increased when Carbetocin is combined with Lofexidine.


The risk or severity of adverse effects can be increased when tubocurarine is combined with Tramadol.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with Drospirenone.


The risk or severity of adverse effects can be increased when ropinirole is combined with tretinoin.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with cetirizine.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with primidone.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with protriptyline.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when periciazine is combined with olanzapine.


The risk or severity of adverse effects can be increased when oxaprozin is combined with niflumic acid.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with fluvastatin.


The risk or severity of adverse effects can be increased when alclofenac is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when alclofenac is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when EFINACONAZOLE is combined with Rosuvastatin.


The risk or severity of adverse effects can be increased when Phenelzine is combined with phenylpropanolamine.


The risk or severity of adverse effects can be increased when Phenelzine is combined with sulpiride.


The risk or severity of adverse effects can be increased when reserpine is combined with METHOHEXITAL.


The risk or severity of adverse effects can be increased when reserpine is combined with chlordiazepoxide.


The risk or severity of adverse effects can be increased when Tramadol is combined with tizanidine.


The risk or severity of adverse effects can be increased when Tramadol is combined with ERGOTAMINE.


The risk or severity of adverse effects can be increased when Tramadol is combined with furosemide.


The risk or severity of adverse effects can be increased when Halazepam is combined with HEROIN.


The risk or severity of adverse effects can be increased when NALDEMEDINE is combined with Naloxegol.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with propoxyphene.


The risk or severity of adverse effects can be increased when venlafaxine is combined with reserpine.


The risk or severity of adverse effects can be increased when bifonazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when bifonazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when amobarbital is combined with Tolcapone.


The risk or severity of adverse effects can be increased when Phenelzine is combined with thiothixene.


The risk or severity of adverse effects can be increased when CICLOPIROX is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when Phenelzine is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when bifonazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when METHAMPHETAMINE is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when Melatonin is combined with fludiazepam.


The risk or severity of adverse effects can be increased when bifonazole is combined with manidipine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with procaine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with apraclonidine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with butalbital.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with trimipramine.


The risk or severity of adverse effects can be increased when Eplerenone is combined with Nebivolol.


The risk or severity of adverse effects can be increased when estazolam is combined with paroxetine.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with aspirin.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with irbesartan.


The risk or severity of adverse effects can be increased when nabumetone is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when VERAPAMIL is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when promazine is combined with prilocaine.


The risk or severity of adverse effects can be increased when nitrous oxide is combined with fexofenadine.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with enflurane.


The risk or severity of adverse effects can be increased when prazepam is combined with sertraline.


The risk or severity of adverse effects can be increased when Carbetocin is combined with carvedilol.


The risk or severity of adverse effects can be increased when nadolol is combined with quetiapine.


The risk or severity of adverse effects can be increased when thalidomide is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with butalbital.


The risk or severity of adverse effects can be increased when barnidipine is combined with clomipramine.


The risk or severity of adverse effects can be increased when barnidipine is combined with epoprostenol.


The risk or severity of adverse effects can be increased when barnidipine is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when barnidipine is combined with bepridil.


The risk or severity of adverse effects can be increased when CHLOROPROCAINE is combined with efavirenz.


The risk or severity of adverse effects can be increased when buspirone is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when pentazocine is combined with cyclobenzaprine.


The risk or severity of adverse effects can be increased when codeine is combined with quetiapine.


The risk or severity of adverse effects can be increased when buspirone is combined with oxprenolol.


The risk or severity of adverse effects can be increased when ketorolac is combined with flunisolide.


The risk or severity of adverse effects can be increased when sulfasalazine is combined with resveratrol.


The risk or severity of adverse effects can be increased when buspirone is combined with prazepam.


The risk or severity of adverse effects can be increased when alprazolam is combined with butorphanol.


The risk or severity of adverse effects can be increased when meperidine is combined with ethchlorvynol.


The risk or severity of adverse effects can be increased when minoxidil is combined with penbutolol.


The risk or severity of adverse effects can be increased when loxapine is combined with promethazine.


The risk or severity of adverse effects can be increased when meperidine is combined with baclofen.


The risk or severity of adverse effects can be increased when flunitrazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with amcinonide.


The risk or severity of adverse effects can be increased when diazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when oxazepam is combined with gabapentin.


The risk or severity of adverse effects can be increased when FLUOCORTOLONE is combined with Demecarium.


The risk or severity of adverse effects can be increased when diazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with PAMIDRONIC ACID.


The risk or severity of adverse effects can be increased when mycophenolate mofetil is combined with Apremilast.


The risk or severity of adverse effects can be increased when mecamylamine is combined with methscopolamine.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when Escitalopram is combined with Flupentixol.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with terazosin.


The risk or severity of adverse effects can be increased when gabapentin is combined with estazolam.


The risk or severity of adverse effects can be increased when FLUPHENAZINE is combined with trazodone.


The risk or severity of adverse effects can be increased when butalbital is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when TRIMETHAPHAN is combined with Metixene.


The risk or severity of adverse effects can be increased when nisoldipine is combined with nicardipine.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with metolazone.


The risk or severity of adverse effects can be increased when nabumetone is combined with flumethasone.


The risk or severity of adverse effects can be increased when antipyrine is combined with Zoledronic acid.


The risk or severity of adverse effects can be increased when antipyrine is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when salicylamide is combined with fenbufen.


The risk or severity of adverse effects can be increased when hydroflumethiazide is combined with Sacubitril.


The risk or severity of adverse effects can be increased when Lofexidine is combined with thalidomide.


The risk or severity of adverse effects can be increased when Crizotinib is combined with atorvastatin.


The risk or severity of adverse effects can be increased when meperidine is combined with loratadine.


The risk or severity of adverse effects can be increased when nitric oxide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when meperidine is combined with imipramine.


The risk or severity of adverse effects can be increased when dyphylline is combined with Indacaterol.


The risk or severity of adverse effects can be increased when Paliperidone is combined with mepivacaine.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with ketoprofen.


The risk or severity of adverse effects can be increased when Ibrutinib is combined with pentoxifylline.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with clonazepam.


The risk or severity of adverse effects can be increased when ethchlorvynol is combined with butalbital.


The risk or severity of adverse effects can be increased when baclofen is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Rotigotine is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when Agomelatine is combined with Desloratadine.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with Melatonin.


The risk or severity of adverse effects can be increased when methysergide is combined with josamycin.


The risk or severity of adverse effects can be increased when butorphanol is combined with dyclonine.


The risk or severity of adverse effects can be increased when Treprostinil is combined with diclofenac.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with proparacaine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Halazepam.


The risk or severity of adverse effects can be increased when nicergoline is combined with Capsaicin.


The risk or severity of adverse effects can be increased when pentosan polysulfate is combined with aspirin.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with meclofenamic acid.


The risk or severity of adverse effects can be increased when indomethacin is combined with Icatibant.


The risk or severity of adverse effects can be increased when morphine is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Remoxipride is combined with Iloperidone.


The risk or severity of adverse effects can be increased when rasagiline is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when ritonavir is combined with disulfiram.


The risk or severity of adverse effects can be increased when methylergonovine is combined with bromocriptine.


The risk or severity of adverse effects can be increased when morphine is combined with thiothixene.


The risk or severity of adverse effects can be increased when furosemide is combined with isoxsuprine.


The risk or severity of adverse effects can be increased when tolmetin is combined with fenoprofen.


The risk or severity of adverse effects can be increased when amphotericin b is combined with acebutolol.


The risk or severity of adverse effects can be increased when meclofenamic acid is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when ketoprofen is combined with paramethasone.


The risk or severity of adverse effects can be increased when paroxetine is combined with DESMOPRESSIN.


The risk or severity of adverse effects can be increased when CARTEOLOL is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when nabumetone is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when prazepam is combined with amitriptyline.


The risk or severity of adverse effects can be increased when thioridazine is combined with Riociguat.


The risk or severity of adverse effects can be increased when Tramadol is combined with nitrous oxide.


The risk or severity of adverse effects can be increased when 5-Fluorocytosine is combined with Risedronic acid.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Ramelteon.


The risk or severity of adverse effects can be increased when desoximetasone is combined with tubocurarine.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when KETAZOLAM is combined with ethosuximide.


The risk or severity of adverse effects can be increased when GALLAMINE TRIETHIODIDE is combined with mecamylamine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with TRICHLOROETHYLENE.


The risk or severity of adverse effects can be increased when ILOPROST is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Aliskiren.


The risk or severity of adverse effects can be increased when Pregabalin is combined with Pitavastatin.


The risk or severity of adverse effects can be increased when gabapentin is combined with Milnacipran.


The risk or severity of adverse effects can be increased when Salsalate is combined with Icatibant.


The risk or severity of adverse effects can be increased when timolol is combined with pilocarpine.


The risk or severity of adverse effects can be increased when triprolidine is combined with dantrolene.


The risk or severity of adverse effects can be increased when nimesulide is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when PERINDOPRIL is combined with indapamide.


The risk or severity of adverse effects can be increased when Rufinamide is combined with zotepine.


The risk or severity of adverse effects can be increased when Rufinamide is combined with MELPERONE.


The risk or severity of adverse effects can be increased when hexetidine is combined with nifedipine.


The risk or severity of adverse effects can be increased when Tramadol is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with Demecarium.


The risk or severity of adverse effects can be increased when leflunomide is combined with flumethasone.


The risk or severity of adverse effects can be increased when enalapril is combined with oxyphenbutazone.


The risk or severity of adverse effects can be increased when loteprednol is combined with mefloquine.


The risk or severity of adverse effects can be increased when thiopental is combined with benzocaine.


The risk or severity of adverse effects can be increased when thiopental is combined with vigabatrin.


The risk or severity of adverse effects can be increased when HEROIN is combined with cyclothiazide.


The risk or severity of adverse effects can be increased when Tramadol is combined with chlorthalidone.


The risk or severity of adverse effects can be increased when tolmetin is combined with prednisone.


The risk or severity of adverse effects can be increased when Flibanserin is combined with Pizotifen.


The risk or severity of adverse effects can be increased when Hexobarbital is combined with maprotiline.


The risk or severity of adverse effects can be increased when azelastine is combined with Ibandronic Acid.


The risk or severity of adverse effects can be increased when METHSUXIMIDE is combined with Escitalopram.


The risk or severity of adverse effects can be increased when diclofenac is combined with mefenamic acid.


The risk or severity of adverse effects can be increased when Talniflumate is combined with ibuprofen.


The risk or severity of adverse effects can be increased when clonidine is combined with Difenoxin.


The risk or severity of adverse effects can be increased when mycophenolic acid is combined with ETOFENAMATE.


The risk or severity of adverse effects can be increased when amoxapine is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Tolcapone.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with amitriptyline.


The risk or severity of adverse effects can be increased when cabergoline is combined with cisapride.


The risk or severity of adverse effects can be increased when rizatriptan is combined with Pipamperone.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with sevoflurane.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with levodopa.


The risk or severity of adverse effects can be increased when Etidocaine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when cocaine is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Articaine.


The risk or severity of adverse effects can be increased when atenolol is combined with triamterene.


The risk or severity of adverse effects can be increased when chlortetracycline is combined with Alitretinoin.


The risk or severity of adverse effects can be increased when oxybutynin is combined with Vecuronium.


The risk or severity of adverse effects can be increased when zonisamide is combined with doxepin.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when carprofen is combined with azelastine.


The risk or severity of adverse effects can be increased when scopolamine is combined with cyclopentolate.


The risk or severity of adverse effects can be increased when Dehydroepiandrosterone is combined with edrophonium.


The risk or severity of adverse effects can be increased when arsenic trioxide is combined with trandolapril.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with procaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with trimipramine.


The risk or severity of adverse effects can be increased when trimipramine is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with amisulpride.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with rivastigmine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when imipramine is combined with dantrolene.


The risk or severity of adverse effects can be increased when CLOBETASOL PROPIONATE is combined with physostigmine.


The risk or severity of adverse effects can be increased when imipramine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when butabarbital is combined with glutethimide.


The risk or severity of adverse effects can be increased when promazine is combined with diazepam.


The risk or severity of adverse effects can be increased when METHOHEXITAL is combined with DIHYDROCODEINE.


The risk or severity of adverse effects can be increased when nisoldipine is combined with irbesartan.


The risk or severity of adverse effects can be increased when Clofarabine is combined with enalapril.


The risk or severity of adverse effects can be increased when fenoldopam is combined with AMILORIDE.


The risk or severity of adverse effects can be increased when Tolcapone is combined with tiagabine.


The risk or severity of adverse effects can be increased when GUANFACINE is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when nisoldipine is combined with felodipine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with prilocaine.


The risk or severity of adverse effects can be increased when felodipine is combined with Nebivolol.


The risk or severity of adverse effects can be increased when nisoldipine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when lithium ion is combined with tizanidine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with butamben.


The risk or severity of adverse effects can be increased when floctafenine is combined with Propacetamol.


The risk or severity of adverse effects can be increased when levorphanol is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with triamterene.


The risk or severity of adverse effects can be increased when mepivacaine is combined with MELPERONE.


The risk or severity of adverse effects can be increased when nitrendipine is combined with D-mannitol.


The risk or severity of adverse effects can be increased when prilocaine is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when betamethasone is combined with physostigmine.


The risk or severity of adverse effects can be increased when ADAPALENE is combined with Mometasone.


The risk or severity of adverse effects can be increased when nisoldipine is combined with penbutolol.


The risk or severity of adverse effects can be increased when Olsalazine is combined with Dehydroepiandrosterone.


The risk or severity of adverse effects can be increased when betamethasone is combined with rivastigmine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when tenoxicam is combined with Icatibant.


The risk or severity of adverse effects can be increased when Olmesartan is combined with tolfenamic acid.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Droxicam.


The risk or severity of adverse effects can be increased when sertraline is combined with doxepin.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with toremifene.


The risk or severity of adverse effects can be increased when Nabilone is combined with Nitroprusside.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Erlotinib.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with ciprofloxacin.


The risk or severity of adverse effects can be increased when Clofarabine is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when NEOSTIGMINE is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Paliperidone.


The risk or severity of adverse effects can be increased when olanzapine is combined with chlorpheniramine.


The risk or severity of adverse effects can be increased when Agomelatine is combined with venlafaxine.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with celecoxib.


The risk or severity of adverse effects can be increased when butorphanol is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with pirenzepine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with isradipine.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Metipranolol.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Olmesartan.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with Telmisartan.


The risk or severity of adverse effects can be increased when sevoflurane is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when propoxyphene is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when procaine is combined with Butethal.


The risk or severity of adverse effects can be increased when sevoflurane is combined with dantrolene.


The risk or severity of adverse effects can be increased when propoxyphene is combined with Ramelteon.


The risk or severity of adverse effects can be increased when reserpine is combined with ALFENTANIL.


The risk or severity of adverse effects can be increased when salicylic acid is combined with Clevidipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with manidipine.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when leflunomide is combined with loteprednol.


The risk or severity of adverse effects can be increased when physostigmine is combined with Carbamylcholine.


The risk or severity of adverse effects can be increased when sulconazole is combined with Benidipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with Azelnidipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with Lacidipine.


The risk or severity of adverse effects can be increased when sulconazole is combined with Efonidipine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with BECLOMETHASONE DIPROPIONATE.


The risk or severity of adverse effects can be increased when lorazepam is combined with tetracaine.


The risk or severity of adverse effects can be increased when leflunomide is combined with niflumic acid.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with moclobemide.


The risk or severity of adverse effects can be increased when methadone is combined with Mersalyl.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with paramethasone.


The risk or severity of adverse effects can be increased when methadone is combined with Ketobemidone.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Bortezomib.


The risk or severity of adverse effects can be increased when metoprolol is combined with Varenicline.


The risk or severity of adverse effects can be increased when rapamycin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when azelastine is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when procarbazine is combined with promazine.


The risk or severity of adverse effects can be increased when Arotinolol is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Asenapine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Arotinolol is combined with Cevimeline.


The risk or severity of adverse effects can be increased when Arotinolol is combined with nicotine.


The risk or severity of adverse effects can be increased when ethyl loflazepate is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Naftifine is combined with bepridil.


The risk or severity of adverse effects can be increased when fludrocortisone is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Naftifine is combined with eperisone.


The risk or severity of adverse effects can be increased when carprofen is combined with ketoprofen.


The risk or severity of adverse effects can be increased when resveratrol is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when estazolam is combined with flunarizine.


The risk or severity of adverse effects can be increased when Olmesartan is combined with sulfasalazine.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with paroxetine.


The risk or severity of adverse effects can be increased when promazine is combined with 4-Hydroxybutanoic acid.


The risk or severity of adverse effects can be increased when Olmesartan is combined with Candesartan cilexetil.


The risk or severity of adverse effects can be increased when Olmesartan is combined with PERINDOPRIL.


The risk or severity of adverse effects can be increased when Naftifine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when Naftifine is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when mepivacaine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Micafungin is combined with nisoldipine.


The risk or severity of adverse effects can be increased when propoxyphene is combined with procarbazine.


The risk or severity of adverse effects can be increased when estazolam is combined with TETRABENAZINE.


The risk or severity of adverse effects can be increased when promazine is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when Pramocaine is combined with Retigabine.


The risk or severity of adverse effects can be increased when antipyrine is combined with homoharringtonine.


The risk or severity of adverse effects can be increased when Naftifine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when propoxyphene is combined with CHLOROPROCAINE.


The risk or severity of adverse effects can be increased when fosinopril is combined with CARTEOLOL.


The risk or severity of adverse effects can be increased when Pipamperone is combined with nimodipine.


The risk or severity of adverse effects can be increased when Pipamperone is combined with carisoprodol.


The risk or severity of adverse effects can be increased when meperidine is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Carbetocin is combined with D-mannitol.


The risk or severity of adverse effects can be increased when Lurasidone is combined with thiamylal.


The risk or severity of adverse effects can be increased when Lurasidone is combined with desipramine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when Lurasidone is combined with halothane.


The risk or severity of adverse effects can be increased when Arotinolol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Remoxipride.


The risk or severity of adverse effects can be increased when bromocriptine is combined with metronidazole.


The risk or severity of adverse effects can be increased when bromocriptine is combined with Repaglinide.


The risk or severity of adverse effects can be increased when dibucaine is combined with etizolam.


The risk or severity of adverse effects can be increased when oxymorphone is combined with hydroflumethiazide.


The risk or severity of adverse effects can be increased when diclofenac is combined with halcinonide.


The risk or severity of adverse effects can be increased when oxymorphone is combined with clidinium.


The risk or severity of adverse effects can be increased when apraclonidine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when DEXKETOPROFEN is combined with acemetacin.


The risk or severity of adverse effects can be increased when losartan is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when UMECLIDINIUM is combined with morphine.


The risk or severity of adverse effects can be increased when tropicamide is combined with Vecuronium.


The risk or severity of adverse effects can be increased when Normethadone is combined with Ramelteon.


The risk or severity of adverse effects can be increased when warfarin is combined with Nintedanib.


The risk or severity of adverse effects can be increased when isoflurane is combined with BISOPROLOL.


The risk or severity of adverse effects can be increased when Frovatriptan is combined with reserpine.


The risk or severity of adverse effects can be increased when MELPERONE is combined with trimipramine.


The risk or severity of adverse effects can be increased when spironolactone is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Propacetamol.


The risk or severity of adverse effects can be increased when secobarbital is combined with thiothixene.


The risk or severity of adverse effects can be increased when secobarbital is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when Etidocaine is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when clonidine is combined with vigabatrin.


The risk or severity of adverse effects can be increased when secobarbital is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with L-phenylalanine.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with nefazodone.


The risk or severity of adverse effects can be increased when clidinium is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when meperidine is combined with Lurasidone.


The risk or severity of adverse effects can be increased when Lormetazepam is combined with doxepin.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when fludiazepam is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when etizolam is combined with doxepin.


The risk or severity of adverse effects can be increased when amphotericin b is combined with imipramine.


The risk or severity of adverse effects can be increased when amphotericin b is combined with prazosin.


The risk or severity of adverse effects can be increased when BISOPROLOL is combined with methazolamide.


The risk or severity of adverse effects can be increased when clidinium is combined with Escitalopram.


The risk or severity of adverse effects can be increased when Paliperidone is combined with DEZOCINE.


The risk or severity of adverse effects can be increased when pentazocine is combined with Drospirenone.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when Paliperidone is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with quetiapine.


The risk or severity of adverse effects can be increased when Pizotifen is combined with Pomalidomide.


The risk or severity of adverse effects can be increased when Spirapril is combined with resveratrol.


The risk or severity of adverse effects can be increased when methylergonovine is combined with atorvastatin.


The risk or severity of adverse effects can be increased when lidocaine is combined with ethosuximide.


The risk or severity of adverse effects can be increased when methylergonovine is combined with Atazanavir.


The risk or severity of adverse effects can be increased when loteprednol is combined with Deferasirox.


The risk or severity of adverse effects can be increased when LISURIDE is combined with pimozide.


The risk or severity of adverse effects can be increased when flurazepam is combined with fexofenadine.


The risk or severity of adverse effects can be increased when timolol is combined with floctafenine.


The risk or severity of adverse effects can be increased when lidocaine is combined with thiopental.


The risk or severity of adverse effects can be increased when Droxicam is combined with Deferasirox.


The risk or severity of adverse effects can be increased when prilocaine is combined with fluoxetine.


The risk or severity of adverse effects can be increased when Melatonin is combined with Olopatadine.


The risk or severity of adverse effects can be increased when Propoxycaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when prilocaine is combined with duloxetine.


The risk or severity of adverse effects can be increased when oxyphenbutazone is combined with acemetacin.


The risk or severity of adverse effects can be increased when celecoxib is combined with BENZYDAMINE.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with MELPERONE.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with zotepine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with Levetiracetam.


The risk or severity of adverse effects can be increased when desipramine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when propofol is combined with nalbuphine.


The risk or severity of adverse effects can be increased when clomipramine is combined with Metipranolol.


The risk or severity of adverse effects can be increased when zaleplon is combined with mepivacaine.


The risk or severity of adverse effects can be increased when clomipramine is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when secobarbital is combined with vigabatrin.


The risk or severity of adverse effects can be increased when Caspofungin is combined with nilvadipine.


The risk or severity of adverse effects can be increased when zaltoprofen is combined with Etidronic acid.


The risk or severity of adverse effects can be increased when loxapine is combined with METAXALONE.


The risk or severity of adverse effects can be increased when Olopatadine is combined with mycophenolic acid.


The risk or severity of adverse effects can be increased when zopiclone is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when triazolam is combined with sertraline.


The risk or severity of adverse effects can be increased when Quinupristin is combined with atorvastatin.


The risk or severity of adverse effects can be increased when triazolam is combined with pimozide.


The risk or severity of adverse effects can be increased when isoflurane is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when fludiazepam is combined with Agomelatine.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when vigabatrin is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when procaine is combined with benzocaine.


The risk or severity of adverse effects can be increased when lidocaine is combined with CYCLIZINE.


The risk or severity of adverse effects can be increased when lidocaine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when lorazepam is combined with benzocaine.


The risk or severity of adverse effects can be increased when ketorolac is combined with diflunisal.


The risk or severity of adverse effects can be increased when Aceclofenac is combined with alclofenac.


The risk or severity of adverse effects can be increased when lorazepam is combined with DIPHENOXYLATE.


The risk or severity of adverse effects can be increased when lorazepam is combined with vigabatrin.


The risk or severity of adverse effects can be increased when chlormezanone is combined with zotepine.


The risk or severity of adverse effects can be increased when chlormezanone is combined with MELPERONE.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with atorvastatin.


The risk or severity of adverse effects can be increased when MORICIZINE is combined with amoxapine.


The risk or severity of adverse effects can be increased when LISURIDE is combined with antipyrine.


The risk or severity of adverse effects can be increased when dyclonine is combined with meclizine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Tolvaptan.


The risk or severity of adverse effects can be increased when methylphenidate is combined with apomorphine.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Asenapine.


The risk or severity of adverse effects can be increased when Butethal is combined with topiramate.


The risk or severity of adverse effects can be increased when folinic acid is combined with CAPECITABINE.


The risk or severity of adverse effects can be increased when diphenhydramine is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when tolazoline is combined with nitroglycerin.


The risk or severity of adverse effects can be increased when phenoxybenzamine is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when FLUOCINOLONE ACETONIDE is combined with nalidixic acid.


The risk or severity of adverse effects can be increased when nitroglycerin is combined with dipyridamole.


The risk or severity of adverse effects can be increased when levorphanol is combined with polythiazide.


The risk or severity of adverse effects can be increased when hydromorphone is combined with Levocetirizine.


The risk or severity of adverse effects can be increased when sulindac is combined with Tixocortol.


The risk or severity of adverse effects can be increased when clemastine is combined with Pizotifen.


The risk or severity of adverse effects can be increased when fenbufen is combined with budesonide.


The risk or severity of adverse effects can be increased when HEROIN is combined with dantrolene.


The risk or severity of adverse effects can be increased when acebutolol is combined with Aliskiren.


The risk or severity of adverse effects can be increased when cilostazol is combined with mesalamine.


The risk or severity of adverse effects can be increased when rapamycin is combined with gabapentin.


The risk or severity of adverse effects can be increased when Aceprometazine is combined with Flibanserin.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with amoxapine.


The risk or severity of adverse effects can be increased when zolmitriptan is combined with nortriptyline.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with fluocinonide.


The risk or severity of adverse effects can be increased when triflupromazine is combined with levodopa.


The risk or severity of adverse effects can be increased when chloroquine is combined with aspirin.


The risk or severity of adverse effects can be increased when etizolam is combined with clozapine.


The risk or severity of adverse effects can be increased when zaleplon is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when docetaxel is combined with Temsirolimus.


The risk or severity of adverse effects can be increased when moclobemide is combined with Zuclopenthixol.


The risk or severity of adverse effects can be increased when moclobemide is combined with Thioproperazine.


The risk or severity of adverse effects can be increased when moclobemide is combined with thiothixene.


The risk or severity of adverse effects can be increased when amobarbital is combined with Pizotifen.


The risk or severity of adverse effects can be increased when isradipine is combined with spironolactone.


The risk or severity of adverse effects can be increased when cilazapril is combined with Salsalate.


The risk or severity of adverse effects can be increased when NATAMYCIN is combined with gabapentin.


The risk or severity of adverse effects can be increased when proparacaine is combined with amitriptyline.


The risk or severity of adverse effects can be increased when proparacaine is combined with Tolcapone.


The risk or severity of adverse effects can be increased when diflorasone is combined with Demecarium.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Aceprometazine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when triazolam is combined with topiramate.


The risk or severity of adverse effects can be increased when quinapril is combined with azelastine.


The risk or severity of adverse effects can be increased when methylergonovine is combined with clofazimine.


The risk or severity of adverse effects can be increased when Levobupivacaine is combined with MOLINDONE.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when CLOCORTOLONE is combined with pyridostigmine.


The risk or severity of adverse effects can be increased when MOEXIPRIL is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when thiopental is combined with prazepam.


The risk or severity of adverse effects can be increased when sertraline is combined with Pipamperone.


The risk or severity of adverse effects can be increased when Etomidate is combined with fludiazepam.


The risk or severity of adverse effects can be increased when sertraline is combined with Tianeptine.


The risk or severity of adverse effects can be increased when prednisone is combined with edrophonium.


The risk or severity of adverse effects can be increased when metaproterenol is combined with terbutaline.


The risk or severity of adverse effects can be increased when ramipril is combined with metolazone.


The risk or severity of adverse effects can be increased when tolterodine is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when floctafenine is combined with fluocinonide.


The risk or severity of adverse effects can be increased when Dexbrompheniramine is combined with paroxetine.


The risk or severity of adverse effects can be increased when Clofarabine is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when estazolam is combined with methoxyflurane.


The risk or severity of adverse effects can be increased when Icatibant is combined with CLOBETASOL PROPIONATE.


The risk or severity of adverse effects can be increased when halothane is combined with Iloperidone.


The risk or severity of adverse effects can be increased when dyclonine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when codeine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when codeine is combined with bumetanide.


The risk or severity of adverse effects can be increased when clomipramine is combined with nicardipine.


The risk or severity of adverse effects can be increased when dyclonine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when sulpiride is combined with Etidocaine.


The risk or severity of adverse effects can be increased when cilostazol is combined with diflunisal.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with Tolcapone.


The risk or severity of adverse effects can be increased when quazepam is combined with etizolam.


The risk or severity of adverse effects can be increased when doxycycline is combined with ADAPALENE.


The risk or severity of adverse effects can be increased when nortriptyline is combined with Sodium phosphate monobasic.


The risk or severity of adverse effects can be increased when Propacetamol is combined with diflorasone.


The risk or severity of adverse effects can be increased when nimesulide is combined with diflunisal.


The risk or severity of adverse effects can be increased when lithium ion is combined with STIRIPENTOL.


The risk or severity of adverse effects can be increased when hydromorphone is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when codeine is combined with Phenelzine.


The risk or severity of adverse effects can be increased when CORTISONE ACETATE is combined with leflunomide.


The risk or severity of adverse effects can be increased when meprobamate is combined with Methadyl acetate.


The risk or severity of adverse effects can be increased when meperidine is combined with Flupentixol.


The risk or severity of adverse effects can be increased when sevoflurane is combined with Etidocaine.


The risk or severity of adverse effects can be increased when phenobarbital is combined with DIMENHYDRINATE.


The risk or severity of adverse effects can be increased when LISURIDE is combined with Regorafenib.


The risk or severity of adverse effects can be increased when clomipramine is combined with hydrochlorothiazide.


The risk or severity of adverse effects can be increased when Fencamfamin is combined with meclizine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when glutethimide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with FLUOCORTOLONE.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Fluprednidene.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with zaltoprofen.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with triflupromazine.


The risk or severity of adverse effects can be increased when flurazepam is combined with Fluspirilene.


The risk or severity of adverse effects can be increased when Normethadone is combined with Desloratadine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with haloperidol.


The risk or severity of adverse effects can be increased when mefenamic acid is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when halothane is combined with hydralazine.


The risk or severity of adverse effects can be increased when apomorphine is combined with Carbetocin.


The risk or severity of adverse effects can be increased when MELPERONE is combined with topiramate.


The risk or severity of adverse effects can be increased when haloperidol is combined with Hexobarbital.


The risk or severity of adverse effects can be increased when cabergoline is combined with Levomepromazine.


The risk or severity of adverse effects can be increased when benazepril is combined with Olsalazine.


The risk or severity of adverse effects can be increased when cabergoline is combined with danazol.


The risk or severity of adverse effects can be increased when pimozide is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when Prasugrel is combined with salicylic acid.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with quazepam.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with prazepam.


The risk or severity of adverse effects can be increased when butabarbital is combined with morphine.


The risk or severity of adverse effects can be increased when ramipril is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when thiamylal is combined with nefazodone.


The risk or severity of adverse effects can be increased when chloroquine is combined with Salsalate.


The risk or severity of adverse effects can be increased when Icatibant is combined with Mometasone.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with CLOCORTOLONE.


The risk or severity of adverse effects can be increased when nicardipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when chloroquine is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when DIHYDROCODEINE is combined with KETAZOLAM.


The risk or severity of adverse effects can be increased when nilvadipine is combined with nifedipine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with chlorzoxazone.


The risk or severity of adverse effects can be increased when CLONIXIN is combined with PREDNICARBATE.


The risk or severity of adverse effects can be increased when buprenorphine is combined with bumetanide.


The risk or severity of adverse effects can be increased when Sitagliptin is combined with cyclophosphamide.


The risk or severity of adverse effects can be increased when buprenorphine is combined with chlorothiazide.


The risk or severity of adverse effects can be increased when Aclidinium is combined with morphine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with meclizine.


The risk or severity of adverse effects can be increased when acemetacin is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with isocarboxazid.


The risk or severity of adverse effects can be increased when methyclothiazide is combined with metolazone.


The risk or severity of adverse effects can be increased when dopamine is combined with celiprolol.


The risk or severity of adverse effects can be increased when ritodrine is combined with DOXOFYLLINE.


The risk or severity of adverse effects can be increased when trimeprazine is combined with Escitalopram.


The risk or severity of adverse effects can be increased when diflunisal is combined with Loxoprofen.


The risk or severity of adverse effects can be increased when celecoxib is combined with diflorasone.


The risk or severity of adverse effects can be increased when amisulpride is combined with topiramate.


The risk or severity of adverse effects can be increased when Lacidipine is combined with pramipexole.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with nitrazepam.


The risk or severity of adverse effects can be increased when Metixene is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when meperidine is combined with butorphanol.


The risk or severity of adverse effects can be increased when flurbiprofen is combined with Deferasirox.


The risk or severity of adverse effects can be increased when Rotigotine is combined with irbesartan.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with Midostaurin.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with amisulpride.


The risk or severity of adverse effects can be increased when temazepam is combined with clomipramine.


The risk or severity of adverse effects can be increased when Rotigotine is combined with felodipine.


The risk or severity of adverse effects can be increased when CYCLIZINE is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when Rotigotine is combined with ISOSORBIDE MONONITRATE.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with papaverine.


The risk or severity of adverse effects can be increased when moclobemide is combined with Iloperidone.


The risk or severity of adverse effects can be increased when bromazepam is combined with Melatonin.


The risk or severity of adverse effects can be increased when bupivacaine is combined with Clofarabine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Flupentixol.


The risk or severity of adverse effects can be increased when bromazepam is combined with promethazine.


The risk or severity of adverse effects can be increased when bromazepam is combined with clonazepam.


The risk or severity of adverse effects can be increased when clonazepam is combined with dantrolene.


The risk or severity of adverse effects can be increased when Fesoterodine is combined with REMIFENTANIL.


The risk or severity of adverse effects can be increased when indapamide is combined with Pentyl nitrite.


The risk or severity of adverse effects can be increased when floctafenine is combined with Masoprocol.


The risk or severity of adverse effects can be increased when Vilazodone is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when morphine is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when acemetacin is combined with dexamethasone.


The risk or severity of adverse effects can be increased when fenbufen is combined with alclofenac.


The risk or severity of adverse effects can be increased when risperidone is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when risperidone is combined with flunitrazepam.


The risk or severity of adverse effects can be increased when DIPHENOXYLATE is combined with Canrenoic acid.


The risk or severity of adverse effects can be increased when Torasemide is combined with digoxin.


The risk or severity of adverse effects can be increased when Torasemide is combined with sulpiride.


The risk or severity of adverse effects can be increased when methadone is combined with ethotoin.


The risk or severity of adverse effects can be increased when chlorprothixene is combined with Oxetacaine.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Cariprazine.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with baclofen.


The risk or severity of adverse effects can be increased when Calcium citrate is combined with dihydrotachysterol.


The risk or severity of adverse effects can be increased when floctafenine is combined with sulindac.


The risk or severity of adverse effects can be increased when Choline magnesium trisalicylate is combined with Clodronic Acid.


The risk or severity of adverse effects can be increased when mesalamine is combined with methylprednisolone.


The risk or severity of adverse effects can be increased when methoxyflurane is combined with topiramate.


The risk or severity of adverse effects can be increased when Tramadol is combined with Levobupivacaine.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with prazosin.


The risk or severity of adverse effects can be increased when Tolcapone is combined with AZILSARTAN MEDOXOMIL.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with loratadine.


The risk or severity of adverse effects can be increased when desoximetasone is combined with NICORANDIL.


The risk or severity of adverse effects can be increased when ondansetron is combined with CYPROHEPTADINE.


The risk or severity of adverse effects can be increased when diclofenac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when amcinonide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when oxyphenonium is combined with SUFENTANIL.


The risk or severity of adverse effects can be increased when DESFLURANE is combined with imipramine.


The risk or severity of adverse effects can be increased when zaleplon is combined with clonidine.


The risk or severity of adverse effects can be increased when temazepam is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when trimipramine is combined with dantrolene.


The risk or severity of adverse effects can be increased when Aripiprazole is combined with dyclonine.


The risk or severity of adverse effects can be increased when prilocaine is combined with Fencamfamin.


The risk or severity of adverse effects can be increased when prilocaine is combined with Ethylmorphine.


The risk or severity of adverse effects can be increased when nadolol is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Torasemide is combined with papaverine.


The risk or severity of adverse effects can be increased when sulpiride is combined with tiagabine.


The risk or severity of adverse effects can be increased when Masoprocol is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Torasemide is combined with nifedipine.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nilvadipine.


The risk or severity of adverse effects can be increased when barnidipine is combined with Clevidipine.


The risk or severity of adverse effects can be increased when methazolamide is combined with Metipranolol.


The risk or severity of adverse effects can be increased when benzocaine is combined with Pipamperone.


The risk or severity of adverse effects can be increased when tenoxicam is combined with epirizole.


The risk or severity of adverse effects can be increased when methazolamide is combined with LEVOBUNOLOL.


The risk or severity of adverse effects can be increased when prilocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when ALFENTANIL is combined with Normethadone.


The risk or severity of adverse effects can be increased when Rufinamide is combined with estazolam.


The risk or severity of adverse effects can be increased when Ropivacaine is combined with prazepam.


The risk or severity of adverse effects can be increased when alprazolam is combined with triazolam.


The risk or severity of adverse effects can be increased when METYROSINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when alprazolam is combined with Oxybuprocaine.


The risk or severity of adverse effects can be increased when temazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when bupropion is combined with paroxetine.


The risk or severity of adverse effects can be increased when fludiazepam is combined with triprolidine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with selegiline.


The risk or severity of adverse effects can be increased when gabapentin is combined with DEXMEDETOMIDINE.


The risk or severity of adverse effects can be increased when indapamide is combined with carbamazepine.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Propacetamol.


The risk or severity of adverse effects can be increased when thiopental is combined with Tasimelteon.


The risk or severity of adverse effects can be increased when pergolide is combined with anastrozole.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with Lormetazepam.


The risk or severity of adverse effects can be increased when BENDROFLUMETHIAZIDE is combined with ETHACRYNIC ACID.


The risk or severity of adverse effects can be increased when triflupromazine is combined with trimipramine.


The risk or severity of adverse effects can be increased when atenolol is combined with dichlorphenamide.


The risk or severity of adverse effects can be increased when temazepam is combined with efavirenz.


The risk or severity of adverse effects can be increased when felbamate is combined with GUANFACINE.


The risk or severity of adverse effects can be increased when Trospium is combined with hydromorphone.


The risk or severity of adverse effects can be increased when Lorcaserin is combined with Tadalafil.


The risk or severity of adverse effects can be increased when temazepam is combined with FLUPHENAZINE.


The risk or severity of adverse effects can be increased when ZILEUTON is combined with FLUTICASONE PROPIONATE.


The risk or severity of adverse effects can be increased when epirizole is combined with prednisone.


The risk or severity of adverse effects can be increased when epirizole is combined with ALENDRONIC ACID.


The risk or severity of adverse effects can be increased when pergolide is combined with pilocarpine.


The risk or severity of adverse effects can be increased when pergolide is combined with PRIMAQUINE.


The risk or severity of adverse effects can be increased when quinapril is combined with nimesulide.


The risk or severity of adverse effects can be increased when nystatin is combined with nimesulide.


The risk or severity of adverse effects can be increased when floctafenine is combined with SERATRODAST.


The risk or severity of adverse effects can be increased when Nitroprusside is combined with penbutolol.


The risk or severity of adverse effects can be increased when ketamine is combined with triflupromazine.


The risk or severity of adverse effects can be increased when Levomilnacipran is combined with SERTINDOLE.


The risk or severity of adverse effects can be increased when floctafenine is combined with Aceclofenac.


The risk or severity of adverse effects can be increased when zopiclone is combined with tranylcypromine.


The risk or severity of adverse effects can be increased when dicyclomine is combined with HEROIN.


The risk or severity of adverse effects can be increased when zopiclone is combined with prilocaine.


The risk or severity of adverse effects can be increased when morphine is combined with indapamide.


The risk or severity of adverse effects can be increased when zopiclone is combined with ethotoin.


The risk or severity of adverse effects can be increased when Candesartan cilexetil is combined with Teriflunomide.


The risk or severity of adverse effects can be increased when morphine is combined with Halazepam.


The risk or severity of adverse effects can be increased when betaxolol is combined with triamterene.


The risk or severity of adverse effects can be increased when pimozide is combined with Remoxipride.


The risk or severity of adverse effects can be increased when thioridazine is combined with ethyl loflazepate.


The risk or severity of adverse effects can be increased when prochlorperazine is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when carisoprodol is combined with triprolidine.


The risk or severity of adverse effects can be increased when Canagliflozin is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when Flupentixol is combined with oxprenolol.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with Olsalazine.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Pizotifen.


The risk or severity of adverse effects can be increased when etodolac is combined with RIMEXOLONE.


The risk or severity of adverse effects can be increased when phenobarbital is combined with fludiazepam.


The risk or severity of adverse effects can be increased when pentazocine is combined with theobromine.


The risk or severity of adverse effects can be increased when oxprenolol is combined with amisulpride.


The risk or severity of adverse effects can be increased when lithium ion is combined with loratadine.


The risk or severity of adverse effects can be increased when Oxybuprocaine is combined with meclizine.


The risk or severity of adverse effects can be increased when desipramine is combined with clenbuterol.


The risk or severity of adverse effects can be increased when Tramadol is combined with flurazepam.


The risk or severity of adverse effects can be increased when oxazepam is combined with paroxetine.


The risk or severity of adverse effects can be increased when Flupentixol is combined with Fosphenytoin.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Etomidate.


The risk or severity of adverse effects can be increased when glutethimide is combined with phenytoin.


The risk or severity of adverse effects can be increased when pergolide is combined with midazolam.


The risk or severity of adverse effects can be increased when midazolam is combined with ondansetron.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with Ropivacaine.


The risk or severity of adverse effects can be increased when chlordiazepoxide is combined with bupivacaine.


The risk or severity of adverse effects can be increased when Sacubitril is combined with diltiazem.


The risk or severity of adverse effects can be increased when citalopram is combined with naratriptan.


The risk or severity of adverse effects can be increased when midazolam is combined with zonisamide.


The risk or severity of adverse effects can be increased when Lumiracoxib is combined with CORTISONE ACETATE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with thiopental.


The risk or severity of adverse effects can be increased when VALPROIC ACID is combined with BREXPIPRAZOLE.


The risk or severity of adverse effects can be increased when 4-Hydroxybutanoic acid is combined with VORTIOXETINE.


The risk or severity of adverse effects can be increased when nitrazepam is combined with ethosuximide.


The risk or severity of adverse effects can be increased when flurazepam is combined with Desloratadine.


The risk or severity of adverse effects can be increased when duloxetine is combined with loxapine.


The risk or severity of adverse effects can be increased when SERTINDOLE is combined with flunarizine.


The risk or severity of adverse effects can be increased when celecoxib is combined with Clobetasone.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with felodipine.


The risk or severity of adverse effects can be increased when prazosin is combined with MOEXIPRIL.


The risk or severity of adverse effects can be increased when methylergonovine is combined with tioconazole.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with irbesartan.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with pargyline.


The risk or severity of adverse effects can be increased when Ethylmorphine is combined with Iloperidone.


The risk or severity of adverse effects can be increased when captopril is combined with Magnesium salicylate.


The risk or severity of adverse effects can be increased when diazepam is combined with cocaine.


The risk or severity of adverse effects can be increased when diazepam is combined with tiagabine.


The risk or severity of adverse effects can be increased when Olopatadine is combined with niflumic acid.


The risk or severity of adverse effects can be increased when diazepam is combined with zonisamide.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when DEZOCINE is combined with Pipotiazine.


The risk or severity of adverse effects can be increased when METYROSINE is combined with fluoxetine.


The risk or severity of adverse effects can be increased when REMIFENTANIL is combined with losartan.


The risk or severity of adverse effects can be increased when METYROSINE is combined with duloxetine.


The risk or severity of adverse effects can be increased when celecoxib is combined with DEFLAZACORT.


The risk or severity of adverse effects can be increased when Pimecrolimus is combined with hydrocortisone.


The risk or severity of adverse effects can be increased when Isoconazole is combined with Coenzyme Q10.


The risk or severity of adverse effects can be increased when Ketobemidone is combined with dantrolene.


The risk or severity of adverse effects can be increased when tranylcypromine is combined with periciazine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with fludiazepam.


The risk or severity of adverse effects can be increased when CABAZITAXEL is combined with mechlorethamine.


The risk or severity of adverse effects can be increased when nalbuphine is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with Etidocaine.


The risk or severity of adverse effects can be increased when codeine is combined with prilocaine.


The risk or severity of adverse effects can be increased when TROLAMINE SALICYLATE is combined with Ciclesonide.


The risk or severity of adverse effects can be increased when fluvoxamine is combined with thiopental.


The risk or severity of adverse effects can be increased when alclofenac is combined with flurandrenolide.


The risk or severity of adverse effects can be increased when diflunisal is combined with diflorasone.


The risk or severity of adverse effects can be increased when pentobarbital is combined with METHSUXIMIDE.


The risk or severity of adverse effects can be increased when quetiapine is combined with tiapride.


The risk or severity of adverse effects can be increased when Vecuronium is combined with pentazocine.


The risk or severity of adverse effects can be increased when nicergoline is combined with DALFOPRISTIN.


The risk or severity of adverse effects can be increased when butenafine is combined with VERAPAMIL.


The risk or severity of adverse effects can be increased when Calcium acetate is combined with Paricalcitol.


The risk or severity of adverse effects can be increased when oxiconazole is combined with nifedipine.


The risk or severity of adverse effects can be increased when reserpine is combined with carisoprodol.


The risk or severity of adverse effects can be increased when trifluoperazine is combined with sevoflurane.


The risk or severity of adverse effects can be increased when methysergide is combined with loratadine.


The risk or severity of adverse effects can be increased when DEXMEDETOMIDINE is combined with Dapagliflozin.


The risk or severity of adverse effects can be increased when Ziprasidone is combined with VALPROIC ACID.


The risk or severity of adverse effects can be increased when TETRABENAZINE is combined with Levomilnacipran.


The risk or severity of adverse effects can be increased when carisoprodol is combined with Flibanserin.


The risk or severity of adverse effects can be increased when butorphanol is combined with Olopatadine.


The risk or severity of adverse effects can be increased when cyclobenzaprine is combined with citalopram.


The risk or severity of adverse effects can be increased when lithium ion is combined with HEROIN.


The risk or severity of adverse effects can be increased when Pirlindole is combined with reserpine.


The risk or severity of adverse effects can be increased when ETOFENAMATE is combined with Propacetamol.


The risk or severity of adverse effects can be increased when quinapril is combined with Etoricoxib.


The risk or severity of adverse effects can be increased when triamcinolone is combined with LEVOFLOXACIN.


The risk or severity of adverse effects can be increased when quinapril is combined with Empagliflozin.


The risk or severity of adverse effects can be increased when flunisolide is combined with sparfloxacin.


The risk or severity of adverse effects can be increased when Lurasidone is combined with tizanidine.


The risk or severity of adverse effects can be increased when TASOSARTAN is combined with resveratrol.


The risk or severity of adverse effects can be increased when scopolamine is combined with Propiverine.


The risk or severity of adverse effects can be increased when trazodone is combined with Agomelatine.


The risk or severity of adverse effects can be increased when tretinoin is combined with methyldopa.


The risk or severity of adverse effects can be increased when diflunisal is combined with FLUOCINOLONE ACETONIDE.


The risk or severity of adverse effects can be increased when diflunisal is combined with Halobetasol.


The risk or severity of adverse effects can be increased when nitrendipine is combined with timolol.


The risk or severity of adverse effects can be increased when oxprenolol is combined with Sacubitril.


The risk or severity of adverse effects can be increased when triamcinolone is combined with donepezil.


The risk or severity of adverse effects can be increased when BUPRANOLOL is combined with acetylcholine.


The risk or severity of adverse effects can be increased when Carbetocin is combined with ESMOLOL.


The risk or severity of adverse effects can be increased when Methadyl acetate is combined with triamterene.


The risk or severity of adverse effects can be increased when lorazepam is combined with citalopram.


The risk or severity of adverse effects can be increased when Lornoxicam is combined with triamcinolone.


The risk or severity of adverse effects can be increased when cabergoline is combined with nortriptyline.


The risk or severity of adverse effects can be increased when Tolcapone is combined with clidinium.


The risk or severity of adverse effects can be increased when Efonidipine is combined with simvastatin.


The risk or severity of adverse effects can be increased when ERGOTAMINE is combined with rabeprazole.


The risk or severity of adverse effects can be increased when Lercanidipine is combined with dipyridamole.


The risk or severity of adverse effects can be increased when Tolcapone is combined with acebutolol.


The risk or severity of adverse effects can be increased when cilnidipine is combined with Telmisartan.


The risk or severity of adverse effects can be increased when cilnidipine is combined with apraclonidine.


The risk or severity of adverse effects can be increased when Tolcapone is combined with captopril.


The risk or severity of adverse effects can be increased when cilnidipine is combined with methyldopa.


The risk or severity of adverse effects can be increased when methylergonovine is combined with tofisopam.


The risk or severity of adverse effects can be increased when hydromorphone is combined with chloral hydrate.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with metoclopramide.


The risk or severity of adverse effects can be increased when dihydroergotamine is combined with amoxapine.


The risk or severity of adverse effects can be increased when carbamazepine is combined with Eslicarbazepine acetate.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with chlorprothixene.


The risk or severity of adverse effects can be increased when dextromethorphan is combined with Aripiprazole.


The risk or severity of adverse effects can be increased when diazepam is combined with topiramate.


The risk or severity of adverse effects can be increased when pancuronium is combined with Fesoterodine.


The risk or severity of adverse effects can be increased when tolazoline is combined with Clevidipine.


The risk or severity of adverse effects can be increased when methocarbamol is combined with clomipramine.


The risk or severity of adverse effects can be increased when Bortezomib is combined with AZILSARTAN MEDOXOMIL.